Search ARM

In 2020 TAAV launched its state-of-the-art facility located in San Sebastian, Spain. The facility is comprised of four suites and additional support labs, that are specifically designed for the manufacture of high quality dbDNA™.

The company produces a synthetic DNA, dbDNA™, as an alternative to plasmid DNA for the manufacture of adeno-associated virus (AAV).
We view dbDNA™ as a disruptive technology in the DNA market creating a new industry standard for transfection-based AAV production. Our synthetic process leads to high yield at small scales, shortening manufacturing timelines, facilitating quicker production of AAV and increasing safety by eliminating residual bacterial sequences of plasmid DNA in the AAV product.

Contact TAAV Biomanufacturing Solutions S.L.
Visit Website